Literature DB >> 21131761

Serum fucose level in malignant diseases.

N G Sawke1, G K Sawke.   

Abstract

We review the present knowledge of serum fucose with special attention to its relation with various malignant diseases. We summarize the role of serum fucose as a useful diagnostic and prognostic marker when used singly or in combination. The purpose of this review is to provide an expert opinion on the practical and applied aspect of serum fucose level in clinical practice and research settings. Our review is based on information from published research studies, library books, and electronic searches through Medline and PubMed. The available published data were used as the basis for recommendations. Each of the subsections concludes to provide information to assist the clinicians and the research scientists make informed decisions.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21131761     DOI： 10.4103/0019-509X.73549

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN： 0019-509X            Impact factor:   1.224


  7 in total

1.  Significance of Serum L-fucose Glycoprotein as Cancer Biomarker in Head and Neck Malignancies without Distant Metastasis.

Authors:  Rathan K S Shetty; Satheesh Kumar Bhandary; Arunava Kali
Journal:  J Clin Diagn Res       Date:  2013-12-15

2.  Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer.

Authors:  Jopi J W Mikkonen; Surya P Singh; Ramin Akhi; Tuula Salo; Reijo Lappalainen; Wilfredo A González-Arriagada; Márcio Ajudarte Lopes; Arja M Kullaa; Sami Myllymaa
Journal:  Oncol Lett       Date:  2018-09-07       Impact factor: 2.967

3.  Relationship Between Increased Fucosylation and Metastatic Potential in Colorectal Cancer.

Authors:  Takahiro Osuga; Rishu Takimoto; Michihiro Ono; Masahiro Hirakawa; Makoto Yoshida; Yutaka Okagawa; Naoki Uemura; Yohei Arihara; Yasushi Sato; Fumito Tamura; Tsutomu Sato; Satoshi Iyama; Koji Miyanishi; Kohichi Takada; Tsuyoshi Hayashi; Masayoshi Kobune; Junji Kato
Journal:  J Natl Cancer Inst       Date:  2016-04-13       Impact factor: 13.506

4.  Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach.

Authors:  Makoto Yoshida; Rishu Takimoto; Kazuyuki Murase; Yasushi Sato; Masahiro Hirakawa; Fumito Tamura; Tsutomu Sato; Satoshi Iyama; Takahiro Osuga; Koji Miyanishi; Kohichi Takada; Tsuyoshi Hayashi; Masayoshi Kobune; Junji Kato
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

5.  Correlation of serum levo-fucose levels as a biomarker with tumor node metastasis staging in oral cancer patients.

Authors:  P Redwin Dhas Manchil; E Tatu Joy; M Shashi Kiran; J Eugenia Sherubin; M Farakath Khan; B S Aravind
Journal:  J Pharm Bioallied Sci       Date:  2016-10

6.  Serum fucose level in oral cancer, leukoplakia, and oral sub mucous fibrosis: A biochemical study.

Authors:  Satish Kumar; Ankit Suhag; Sumanta Kumar Kolay; Puneet Kumar; Anumeha Narwal; K Srinivas; Safiya Haideri
Journal:  J Family Med Prim Care       Date:  2019-07

7.  Lectin drug conjugate therapy for colorectal cancer.

Authors:  Daichi Kitaguchi; Tatsuya Oda; Tsuyoshi Enomoto; Yusuke Ohara; Yohei Owada; Yoshimasa Akashi; Tomoaki Furuta; Yang Yu; Sota Kimura; Yukihito Kuroda; Ko Kurimori; Yoshihiro Miyazaki; Kinji Furuya; Osamu Shimomura; Hiroaki Tateno
Journal:  Cancer Sci       Date:  2020-11-02       Impact factor: 6.518
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.